Number | Percent | |
---|---|---|
Surgery | ||
Postoperative RI + systemic therapy | 9 | 33 |
Postoperative RI alone | 3 | 11 |
Definitive RI without surgery | ||
RI + systemic therapy | 12 | 45 |
RI alone | 2 | 7 |
Palliative RI | 1 | 4 |
Concurrent chemotherapy/targeted therapy | ||
Cisplatin-based | 19 | 70 |
Cetuximab | 2 | 7 |
None | 6 | 22 |